Nuvera Biosciences enters into a licensing agreement with Veridex LLC to commercialize its assays for predicting patient response to tamoxifen therapy and taxane-containing chemotherapy in breast cancer.
Read MoreBeckman Coulter Inc has expanded its Renal menu with the addition of Gentian* Cystatin C Immunoassay (CYSX), an assay for the quantitative determination of cystatin C in human serum and plasma.
Read More
BBL CHROMagar MRSA IDs most MRSA within 24 hours The BBL CHROMagar MRSA, from BD Diagnostics, Sparks, Md, allows microbiology laboratories to identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) more quickly
Read MoreIn a new peer-reviewed paper examines the key advantages of using Transgenomic’s Surveyor Nuclease technology for mutation scanning of two important genes used in the diagnosis and prognosis of autosomal dominant polycystic kidney disease.
Read MoreA new study reveals the first-ever genetic link to the reason African-Americans are at increased risk of dying from colon cancer.
Read More